Robert W. Baird Issues Pessimistic Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price objective reduced by Robert W. Baird from $1,369.00 to $1,034.00 in a report issued on Tuesday morning,Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock.

A number of other analysts have also recently commented on MTD. Citigroup upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price objective for the company in a research report on Monday, April 7th. Wells Fargo & Company decreased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 17th. Finally, Evercore ISI boosted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $1,304.25.

Mettler-Toledo International Trading Up 2.6 %

NYSE:MTD opened at $1,073.89 on Tuesday. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,546.93. The company has a market capitalization of $22.38 billion, a P/E ratio of 26.50, a price-to-earnings-growth ratio of 3.30 and a beta of 1.28. The firm has a 50-day moving average price of $1,164.25 and a two-hundred day moving average price of $1,249.32.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, equities research analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Activity

In related news, insider Gerry Keller sold 600 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. This represents a 99.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares in the company, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several large investors have recently added to or reduced their stakes in MTD. JPMorgan Chase & Co. boosted its position in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after buying an additional 28,478 shares during the period. Allworth Financial LP boosted its holdings in Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock worth $285,000 after acquiring an additional 169 shares during the period. Nordea Investment Management AB grew its position in Mettler-Toledo International by 29.8% in the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock valued at $129,919,000 after acquiring an additional 24,285 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its stake in shares of Mettler-Toledo International by 18.0% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier’s stock valued at $42,058,000 after purchasing an additional 5,234 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. lifted its position in shares of Mettler-Toledo International by 773.3% during the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,336 shares of the medical instruments supplier’s stock worth $6,530,000 after purchasing an additional 4,725 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.